Human induced pluripotent stem cells technology in treatment resistant depression: novel strategies and opportunities to unravel ketamine’s fast-acting antidepressant mechanisms

Approximately 30% of Major Depressive Disorder (MDD) patients develop treatment-resistant depression (TRD). Among the different causes that make TRD so challenging in both clinical and research contexts, major roles are played by the inadequate understanding of MDD pathophysiology and the limitation...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ther Adv Psychopharmacol
Egile Nagusiak: Marcatili, Matteo, Sala, Carlo, Dakanalis, Antonios, Colmegna, Fabrizia, D’Agostino, Armando, Gambini, Orsola, Dell’Osso, Bernardo, Benatti, Beatrice, Conti, Luciano, Clerici, Massimo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2020
Gaiak:
Novel Strategies for the Treatment of Depression
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7649879/
https://ncbi.nlm.nih.gov/pubmed/33224469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125320968331
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak